Tag
Reporting or argument about abortion medications, distribution, regulation or use.
Dr. William Evans has lost his authorization to practice medicine after prescribing an ‘abortive’ to a patient who may have been pregnant with his child.
Read →A Louisiana father secretly slipped abortion pills into his pregnant daughter's food. She went into premature labor, and that baby is now fighting for life in a Lafayette NICU. Now a federal...
Read →A North Carolina teenager gave birth into a toilet after ordering abortion pills online. She was 31 weeks pregnant, nearly three times past what the FDA allows. Her baby lived, and he's...
Read →Flanders reports on an indictment alleging that a Kentucky man replaced his pregnant girlfriend's medication with an abortion drug without her knowledge. She summarizes the reported evidence and places the allegation alongside other cases of coerced or nonconsensual abortion.
Read →Louisiana filed a lawsuit against the U.S. Food and Drug Administration (FDA) to restore safety restrictions on abortion pills that were removed by the Biden administration, arguing that the removal of the in-person dispensing requirement undermines state laws and harms women.
Read →Students for Life of America praised the Environmental Protection Agency's proposed study to detect mifepristone and misoprostol in America's drinking water as a victory for common sense, highlighting concerns about chemical abortion pill pollution in water systems. The EPA's study will screen for a broad range of emerging contaminants, including these abortion drugs, following advocacy efforts by Students for Life and support from members of Congress and attorneys general to include mifepristone in mandatory water testing under the Safe Drinking Water Act.
Read →Carafem, a mail-order abortion drug distributor, is partnering with social media influencers to promote at-home chemical abortions through videos that appear as personal experiences but are likely paid advertisements. Live Action's investigation highlights concerns about the safety of mail-order abortion pills, citing data that suggests higher risks of serious adverse reactions and ongoing legal efforts to restore in-person dispensing requirements for abortion pills in the U.S.
Read →The U.S. Fifth Circuit Court of Appeals heard arguments in the Louisiana vs FDA case regarding the FDA's 2023 decision to remove the requirement for an in-person doctor visit before receiving an abortion pill, which Louisiana claims has led to unsafe mailing of abortion pills.
Read →The Court of Appeals heard oral arguments in Louisiana's lawsuit challenging abortion-pill regulations. Louisiana presented arguments based on state sovereignty and Medicaid costs, seeking specific relief in the case.
Read →Novielli reviews oral arguments in Louisiana's challenge to federal rules permitting mailed abortion pills. She describes the state's claims of legal and financial harm and criticism of the federal government's focus on standing.
Read →A new poll underscores the importance of highlighting the danger posed by mail-order abortion pills, which have become widespread since the Biden administration.
Read →MEDIA ADVISORY: Louisiana v. FDA to be argued in the Fifth Circuit Court of Appeals on September 9, 2026. “Louisiana again confronts the dangers of chemical abortion pills in court, and those risks include threats to endangered species, which we detailed in our amicus brief,” said Students for Life’s Kristan Hawkins. “A peer-reviewed study shows that mifepristone and mifepristone equivalents taint the water where it was tested. The risk to ... Read More The post Students for Life Again Supports Louisiana’s Case Against the FDA with an Amicus Brief, As Chemical Abortion Pill Policy to be Debate
Read →Flanders argues that remote access to abortion pills has enabled use later in pregnancy than the FDA-approved regimen. She discusses reported cases and criticizes the removal of in-person dispensing requirements.
Read →SBA Pro-Life America advocates against abortion drugs, highlighting concerns about women being harmed or poisoned against their will. The organization focuses on advancing pro-life laws, electing pro-life leaders, and empowering communities through voter contact programs to protect unborn children and support mothers.
Read →Flanders discusses Sami Parker's criticism of influencer partnerships promoting at-home abortion through Carafem. The article questions how the sponsored content presents the experience and whether important risks and difficulties are omitted.
Read →Sielicki examines a Noble Predictive Insights poll commissioned for Center Square about mailed abortion pills. She reports support for online prescribing alongside respondents' safety concerns and discusses objections from pro-life advocates.
Read →Kentucky Attorney General Russell Coleman sued an organization that promotes mail-order abortion-inducing drugs to women in states where it’s restricted. Coleman announced the litigation Thursday against Mayday Health, a New York-based activist organization, stating the organization broke state law by advertising illegal mail-order abortion pills. Last weekend, Mayday Health chartered an airplane that flew over...
Read →Mia Steupert compares national post-Dobbs abortion estimates from different data sources. The report discusses how interstate travel, mail-order medication, and changing state laws complicate estimates of abortion incidence.
Read →A New York abortion group flew a banner over the Kentucky State Fair advertising illegal abortion drugs, prompting backlash from the state attorney general.
Read →A federal judge on Sunday agreed to the U.S. Food and Drug Administration’s request to pause a lawsuit over the safety of the mifepristone pill and the drug’s mail-order distribution. The post Federal judge delays mifepristone lawsuit until after midterms appeared first on The Catholic Thing .
Read →A Senate inquiry investigated abortion-pill manufacturers and the financial information they provided or withheld. The limited disclosure of revenue by these manufacturers complicates efforts to scrutinize the industry's incentives and accountability.
Read →Flanders argues that abortion pills should not be described as healthcare because their intended outcome ends prenatal life. She also presents safety and regulatory claims that require medical and primary-source review before republication as factual guidance.
Read →Sielicki reports on an abortion-pill advertising banner flown over the Kentucky State Fair by Mayday Health. She summarizes the attorney general's objections and the background of an earlier investigation into the group's advertising.
Read →There is no end to where pro-abortion activists will push their deadly and illegal ideas. MayDay Health, an organization dedicated to pushing women to seek abortions in pro-life states in opposition to those states’ laws, flew a plane over the Kentucky State Fair with a banner stating “ABORTION PILLS BY MAIL” and the company name. The Kentucky State Fair is held each fall hosting over 600,000 visitors, including children and school groups. While ... Read More The post SHAMELESS: MayDay Health Pushes ILLEGAL Abortion Pills on KIDS at Kentucky State Fair appeared first on Students for Life of Am
Read →The U.S. bishops are opponents of permitting distribution of mifepristone by mail, and have called on the Trump administration to rescind it. The post State challenge to policy permitting mifepristone by mail paused until after midterms first appeared on OSV News .
Read →The U.S. bishops are among those who have opposed the policy permitting distribution of mifepristone by mail. The post Federal judge delays states' bid to revoke abortion pill approval until after midterms first appeared on Angelus News .
Read →Flanders reports another pause in a lawsuit brought by Texas and Florida challenging mifepristone's federal approval. She explains that proceedings are expected to resume after the FDA's review or the stated December deadline and notes a denied dismissal motion.
Read →Novielli discusses a Senate report's allegations about abortion-pill manufacturers' oversight of certified prescribers. She links those allegations to company revenue and argues that financial incentives may conflict with enforcement of safety requirements.
Read →A five-month-long investigation by Republicans in the U.S. Senate found that abortion pill manufacturing companies are falling short on critical oversight while bringing in millions of dollars in revenue. The post Senate GOP report finds dangerous lack of guardrails for abortion pill prescriptions appeared first on The Catholic Thing .
Read →Novielli analyzes figures on certified abortion-pill prescribers in relation to the broader physician workforce. She discusses reported reasons for not prescribing, including legal concerns, safety questions, and access to surgical backup.
Read →